Use of Immune Checkpoint Inhibitors in the Treatment of Patients With Cancer and Preexisting Autoimmune Disease.

Autor: Oshima Y; University of Tokyo, Tokyo, Japan (Y.O.)., Hagino N; Teikyo University Medical Center, Chiba, Japan (N.H.)., Hara M; Teikyo University Hospital, Kanagawa, Japan (M.H.)., Ohfuji T; Kohnodai Hospital, National Center for Global Health and Medicine, Chiba, Japan (T.O.).
Jazyk: angličtina
Zdroj: Annals of internal medicine [Ann Intern Med] 2018 Jul 17; Vol. 169 (2), pp. 133.
DOI: 10.7326/L18-0208
Databáze: MEDLINE